📰 Leukemia News
Page 188 - Leukemia News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Leukemia. Real-time updates on events, politics, business and more.
December 14, 2021
Young patients with chronic lymphocytic leukemia (CLL) can enjoy long remissions on the drug ibrutinib, but must stay on it indefinitely to keep the cancer in remission.
December 14, 2021
Press release content from PR Newswire. The AP news staff was not involved in its creation.
December 14, 2021
A little boy from Allen had just one Christmas wish this year – to not spend it at the hospital for his cancer treatment.
December 14, 2021
Estimated 3-year disease-free survival and overall survival rates topped 80% in elderly patients with Philadelphia-chromosome-positive ALL not amenable to chemotherapy.
December 14, 2021
With efficacy and safety appearing to shine, regulatory review finally appears imminent
December 14, 2021
T-cell acute lymphoblastic leukemia (T-ALL) is an aggressive type of leukemia. Despite advances in treatments, patients have an extremely poor prognosis, highlighting the need to explore the genetic components that lead to the formation of T-ALL, as well as the need to discover new targeted therapeutic approaches and treatment resistance.
December 14, 2021
A drug combination can safely prevent transplanted stem cells, known as a graft, from attacking the recipient's body, allowing them to develop into healthy new blood and immune cells, a new study shows.
December 13, 2021
New findings provide preliminary evidence to use aggressive supportive treatment of COVID-19 in patients with acute leukemias and myelodysplastic syndromes.
December 13, 2021
At the 2021 American Society of Hematology (ASH) Annual Meeting Regulatory News: OSE Immunotherapeutics SA (Paris:OSE) (ISIN: FR0012127173; Mnemo: OSE) presented the first preclinical data on
December 13, 2021
- Big Data analyses have produced novel insights that may improve the prognostication of patients with AML and CLL - These Results may be used to identify ...